New vaccine development kick-starts powerful immune response

Researchers have developed an exciting new vaccine substance that could lead to improved immune responses and reduced side-effects for existing vaccines. It could also play a role in developing vaccines for HIV, Tuberculosis and Meningitis, as well as reduce the needs for booster shots. Kathryn Ryan speaks with Victoria University Professors Bridget Stocker and Mattie Timmer about the wider project to target immune cells in an effort to combat cancer.